Area of research
Epidemiology · Critical Care and Intensive Care Medicine
Research interest
Research interests include Pneumonia and Respiratory Infections, Nosocomial Infections in ICU, Respiratory viral infections research, and Sepsis Diagnosis and Treatment.
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Severe community-acquired pneumonia
Initial antimicrobial management of sepsis
Management of pneumonia in critically ill patients
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults
Updates on community acquired pneumonia management in the ICU
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM
Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research
Challenges in severe community-acquired pneumonia: a point-of-view review
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes
Future Research Directions in Pneumonia. NHLBI Working Group Report
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Community-acquired pneumonia related to intracellular pathogens
The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia
Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia